Zenith Drugs Limited IPO – GMP, Review, Share Price, Subscription, and Details

1.Zenith Drugs Limited IPO Overview

The initial public offering (IPO) of Zenith Drugs Limited is a public issue under the SME board. The subscription window is scheduled to open on Feb 19, 2024 and close on Feb 22, 2024, with the price band fixed at ₹75–79 per equity share.

2.Issue Details at a Glance

3.Bidding, Allotment & Listing Timeline

• Bidding opens: Feb 19, 2024
• Bidding closes: Feb 22, 2024
• Allotment date: TBA
• Listing date: 2024-02-27
• Minimum investment: ₹1,20,000 for 1600 shares
• Official document: Download Zenith Drugs Limited RHP PDF

4.Zenith Drugs Limited IPO GMP Today

No grey market premium has been recorded for Zenith Drugs Limited yet. GMP is an informal, unregulated indicator of listing-day sentiment and is not published by any exchange.

5.How to Apply for Zenith Drugs Limited IPO

1. 1Open IPOGMPTracker or use your broker's app or net banking ASBA facility.
2. 2Search for "Zenith Drugs Limited IPO" and select it from the list of current issues.
3. 3Choose your demat account and enter your bid quantity in multiples of the 1600-share lot, at a price within the ₹75–79 band (or bid at cut-off, if eligible).
4. 4Submit the application and approve the UPI mandate request when it arrives — funds stay blocked in your account and are debited only on allotment.

Allotment is expected to be finalised around TBA, with listing tentatively scheduled for 2024-02-27 on BSE and NSE. Once finalised, check your status on the Zenith Drugs Limited IPO allotment status page.

6.How to Track Subscription & Allotment

• Live subscription: Track QIB, NII and retail bidding on the IPO subscription status page
• Allotment status: Check your application on the IPO allotment status page
• Full IPO details: See dates, lot size, reservation and financials on the Zenith Drugs Limited IPO page
• More issues: Browse current IPOs, upcoming IPOs and the IPO event calendar

7.Conclusion

Zenith Drugs Limited opens on Feb 19, 2024 and closes on Feb 22, 2024 at ₹75–79 per share. Read the offer documents in full and consult a qualified adviser before applying — nothing on this page is investment advice.